NYSE:CL - Colgate-Palmolive Stock Price, News, & Analysis

Get Started

$71.20 -0.55 (-0.77 %)

(As of 05/26/2019 11:41 AM ET)

Previous Close$71.20

Today's Range$71.14 - $72.00

52-Week Range$57.41 - $73.10

Volume2.27 million shs

Average Volume3.69 million shs

Market Capitalization$61.13 billion

P/E Ratio23.97

Dividend Yield2.40%

Beta0.81

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners. The company also provides home care products comprising dishwashing detergents, household cleaners, and fabric conditioners; pet nutrition products for everyday nutritional needs; and a range of therapeutic products to manage disease conditions in dogs and cats. Its principal global and regional trademarks include Colgate, Palmolive, elmex, Tom's of Maine, Sorriso, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sanex, Elta MD, PCA Skin, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. The company markets and sells its oral, personal, and home care products to various retailers, wholesalers, and distributors; and pet nutrition products for dogs and cats through pet supply retailers, veterinarians, and e-commerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Receive CL News and Ratings via Email

Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Toilet preparations

Sub-IndustryHousehold Products

SectorConsumer Staples

Current SymbolNYSE:CL

Previous Symbol

CUSIP19416210

CIK21665

Webhttp://www.colgatepalmolive.com/

Phone212-310-2000

Debt

Debt-to-Equity Ratio32.25

Current Ratio1.07

Quick Ratio0.74

Price-To-Earnings

Trailing P/E Ratio23.97

Forward P/E Ratio25.16

P/E Growth4.69

Sales & Book Value

Annual Sales$15.54 billion

Price / Sales3.93

Cash Flow$3.5761 per share

Price / Cash Flow19.91

Book Value($0.24) per share

Price / Book-296.67

Profitability

EPS (Most Recent Fiscal Year)$2.97

Net Income$2.40 billion

Net Margins15.08%

Return on Equity-3,730.37%

Return on Assets20.04%

Miscellaneous

Employees34,500

Outstanding Shares858,515,000

Market Cap$61.13 billion

Next Earnings Date7/26/2019 (Estimated)

OptionableOptionable

Colgate-Palmolive (NYSE:CL) Frequently Asked Questions

What is Colgate-Palmolive's stock symbol?

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?

Colgate-Palmolive announced a quarterly dividend on Thursday, March 14th. Shareholders of record on Friday, April 19th will be given a dividend of $0.43 per share on Wednesday, May 15th. This represents a $1.72 dividend on an annualized basis and a yield of 2.42%. The ex-dividend date of this dividend is Wednesday, April 17th. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.42. View Colgate-Palmolive's Dividend History.

How will Colgate-Palmolive's stock buyback program work?

Colgate-Palmolive announced that its board has initiated a share buyback plan on Monday, June 18th 2018, which permits the company to repurchase $5,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 9% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's management believes its shares are undervalued.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) announced its earnings results on Friday, April, 26th. The company reported $0.67 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.66 by $0.01. The business earned $3.88 billion during the quarter, compared to analyst estimates of $3.86 billion. Colgate-Palmolive had a net margin of 15.08% and a negative return on equity of 3,730.37%. Colgate-Palmolive's revenue was down 2.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.74 earnings per share. View Colgate-Palmolive's Earnings History.

When is Colgate-Palmolive's next earnings date?

Colgate-Palmolive is scheduled to release their next quarterly earnings announcement on Friday, July 26th 2019. View Earnings Estimates for Colgate-Palmolive.

How can I listen to Colgate-Palmolive's earnings call?

Colgate-Palmolive will be holding an earnings conference call on Friday, July 26th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link.

What price target have analysts set for CL?

16 brokers have issued 12 month target prices for Colgate-Palmolive's stock. Their predictions range from $57.00 to $75.00. On average, they expect Colgate-Palmolive's share price to reach $68.7857 in the next year. This suggests that the stock has a possible downside of 3.4%. View Analyst Price Targets for Colgate-Palmolive.

What is the consensus analysts' recommendation for Colgate-Palmolive?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 1 sell rating, 11 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Colgate-Palmolive.

What are Wall Street analysts saying about Colgate-Palmolive stock?

Here are some recent quotes from research analysts about Colgate-Palmolive stock:

1. According to Zacks Investment Research, "Colgate surpassed the industry year to date owing to a robust surprise trend, which continued in first-quarter 2019. This marked the company’s second straight quarter of sales beat and third positive earnings surprise of the last five quarters. Further, robust volumes and favorable pricing aided organic sales growth in the quarter. In 2019, the company expects benefits of pricing and productivity programs to considerably offset rise in raw material costs. Further, accelerated investments in brands, strong innovation, and expansion in new markets and channels, is likely to aid sales growth in 2019. However, the company is plagued with a soft margin trend and currency headwinds for a while now. Soft margins in first-quarter 2019 were due to increased raw material and packaging costs as well as higher SG&A expenses, which should continue throughout 2019. Further, adverse currency is likely to mar earnings and sales in 2019." (5/13/2019)
2. Jefferies Financial Group Inc analysts commented, "We maintain our Hold / $61 PT following the Colgate Total relaunch event in NYC (1/31). Despite clinical advances, significant investment, and improved price/mix, we are less certain the brand is a game changer given consumers’ shift from total care toothpaste products and relatively indistinguishable packaging vs. the existing brand. The stock’s recent bounce leaves valuation full at 22.5x NTM P/E (in-line w/hist. 5% prem. to HPC stocks) – Hold. We attended the Colgate Total re-launch event in NYC (1/31), which was primarily targeted toward media and valued product influencers, that sets the stage for the brand’s official roll-out. We are less certain this is a game-changer as total claim toothpaste brands have lost share in the US and the product’s packaging is relatively indistinguishable vs. its existing namesake product (see Chart 1)." (2/1/2019)
3. Wells Fargo & Co analysts commented, "We especially enjoyed the surprise performance by JoJo and sneak peek at CL’s Super Bowl ad featuring Luke Wilson. We also spent time in CL’s innovation area and saw firsthand the benefits of CL’s extensive R&D including anti-sensitivity, instant neutralization of odors, incremental enamel protection and new flavors. It also helped us conceptualize the significant marketing and promotional support that the brand will receive and as such, we came away feeling better about the potential for success of the Total relaunch. However, we also note that the uptick in spending CL is taking across its entire portfolio to accelerate organic sales growth (we est. +80bps) is also pressuring EPS (which is expected to be down -MSD in FY19)." (1/31/2019)

Has Colgate-Palmolive been receiving favorable news coverage?

Media headlines about CL stock have trended negative on Sunday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Colgate-Palmolive earned a coverage optimism score of -2.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an impact on the stock's share price in the next few days.

Who are some of Colgate-Palmolive's key competitors?

Some companies that are related to Colgate-Palmolive include Estee Lauder Companies (EL), Coty (COTY), Pola Orbis (PORBF), HYPERA S A/S (HYPMY), Inter Parfums (IPAR), Edgewell Personal Care (EPC), Avon Products (AVP), Mandom (MDOMF), Revlon (REV), e.l.f. Beauty (ELF), United-Guardian (UG), 2050 Motors (ETFM) and DS Healthcare Group (DSKX).

What other stocks do shareholders of Colgate-Palmolive own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), PepsiCo (PEP), Intel (INTC), The Coca-Cola (KO), Mcdonald's (MCD), AT&T (t), Verizon Communications (VZ), Walt Disney (DIS) and Exxon Mobil (XOM).

Who are Colgate-Palmolive's key executives?

Colgate-Palmolive's management team includes the folowing people:

Mr. Ian M. Cook, Exec. Chairman (Age 66)
Mr. Noel R. Wallace, Pres, CEO & Director (Age 55)
Mr. Henning I. Jakobsen, Chief Financial Officer (Age 59)
Mr. P. Justin Skala, Exec. VP and Chief Growth & Strategy Officer (Age 59)
Dr. Patricia D. Verduin Ph.D., Chief Technology Officer (Age 60)

Who are Colgate-Palmolive's major shareholders?

Colgate-Palmolive's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.98%), Wellington Management Group LLP (2.78%), First Eagle Investment Management LLC (1.50%), Geode Capital Management LLC (1.48%), Northern Trust Corp (1.27%) and Loomis Sayles & Co. L P (1.25%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive.

Which institutional investors are selling Colgate-Palmolive stock?

CL stock was sold by a variety of institutional investors in the last quarter, including Gyroscope Capital Management Group LLC, Amundi Pioneer Asset Management Inc., Assenagon Asset Management S.A., Flossbach Von Storch AG, Ceredex Value Advisors LLC, BlackRock Inc., Wellington Management Group LLP and Morgan Stanley. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Dennis J Hickey, Franck J Moison, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts and Stephen I Sadove. View Insider Buying and Selling for Colgate-Palmolive.

Which institutional investors are buying Colgate-Palmolive stock?

CL stock was bought by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, FMR LLC, AQR Capital Management LLC, Ronna Sue Cohen, FIL Ltd, CIBC World Markets Inc., California Public Employees Retirement System and Martingale Asset Management L P. View Insider Buying and Selling for Colgate-Palmolive.

How do I buy shares of Colgate-Palmolive?

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Colgate-Palmolive's stock price today?

One share of CL stock can currently be purchased for approximately $71.20.

How big of a company is Colgate-Palmolive?

Colgate-Palmolive has a market capitalization of $61.13 billion and generates $15.54 billion in revenue each year. The company earns $2.40 billion in net income (profit) each year or $2.97 on an earnings per share basis. Colgate-Palmolive employs 34,500 workers across the globe.

What is Colgate-Palmolive's official website?

The official website for Colgate-Palmolive is http://www.colgatepalmolive.com/.

How can I contact Colgate-Palmolive?

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]

MarketBeat Community Rating for Colgate-Palmolive (NYSE CL)

Community Ranking:		1.7 out of 5 ()
Outperform Votes:		399 (Vote Outperform)
Underperform Votes:		792 (Vote Underperform)
Total Votes:		1,191

MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe CL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 5/26/2019 by MarketBeat.com Staff